Nicholas Demet's Colleagues at Trevi Therapeutics
Nicholas Demet's Contact Details
HQ
203-304-2499
203-304-2499
Location
Company
Trevi Therapeutics
Trevi Therapeutics
Nicholas Demet's Company Details
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvio™ (nalbuphine ER). Trevi is conducting a Phase 2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with prurigo nodularis (PN) and a Phase 2 trial for chronic cough in patients with idiopathic pulmonary fibrosis (IPF). These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems, and both are areas of high unmet need. Founded in 2011, Trevi is headquartered in New Haven, CT.
Frequently Asked Questions about Nicholas Demet
Nicholas Demet currently works for Trevi Therapeutics, Inc..
Nicholas Demet's role at Trevi Therapeutics, Inc. is Quality Assurance Associate.
Nicholas Demet's email address is ***@trevitherapeutics.com. To view Nicholas Demet's full email address, please signup to ConnectPlex.
Nicholas Demet works in the Research industry.
Nicholas Demet's colleagues at Trevi Therapeutics are Jennifer Good, Farrell Simon, Sherry Minor, Katherine Takaki, Paula Buckley, Joe Carrino, Kevin Fitzmaurice and others.
Nicholas Demet's phone number is 203-304-2499